[{"address1": "890 Winter Street", "address2": "Suite 200", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 208 2466", "website": "https://upstreambio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 52, "companyOfficers": [{"maxAge": 1, "name": "Dr. E. Rand Sutherland M.D., M.P.H.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 869154, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael Paul Gray CPA, MBA", "age": 53, "title": "CFO & COO", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 607200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Allison C. Ambrose J.D.", "age": 39, "title": "Senior VP, General Counsel & Secretary", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 59792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy  Price M.S., P.M.P.", "age": 55, "title": "Chief Technology Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Meggan  Buckwell", "title": "Director of Corporate Communications & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Fiering", "title": "Senior Vice President of People & Culture", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adam  Houghton M.B.A., Ph.D.", "age": 54, "title": "Chief Business Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Aaron  Deykin M.D.", "age": 57, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 736700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mersedeh  Miraliakbari Pharm.D.", "title": "Senior Vice President of Regulatory Affairs & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Fang  Xie Ph.D.", "title": "VP & Head of Biometrics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 30.27, "open": 30.11, "dayLow": 29.1, "dayHigh": 30.11, "regularMarketPreviousClose": 30.27, "regularMarketOpen": 30.11, "regularMarketDayLow": 29.1, "regularMarketDayHigh": 30.11, "payoutRatio": 0.0, "forwardPE": -9.215668, "volume": 224041, "regularMarketVolume": 224041, "averageVolume": 460890, "averageVolume10days": 665290, "averageDailyVolume10Day": 665290, "bid": 21.5, "ask": 36.32, "bidSize": 2, "askSize": 2, "marketCap": 1593057664, "fiftyTwoWeekLow": 5.14, "fiftyTwoWeekHigh": 33.0, "allTimeHigh": 33.0, "allTimeLow": 5.14, "priceToSalesTrailing12Months": 569.1524, "fiftyDayAverage": 25.9245, "twoHundredDayAverage": 15.902525, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1222049664, "profitMargins": 0.0, "floatShares": 34181030, "sharesOutstanding": 54038591, "sharesShort": 2983568, "sharesShortPriorMonth": 2994056, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0552, "heldPercentInsiders": 0.14773, "heldPercentInstitutions": 0.87458, "shortRatio": 5.49, "shortPercentOfFloat": 0.0995, "impliedSharesOutstanding": 54038591, "bookValue": 7.011, "priceToBook": 4.2048206, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -135815008, "trailingEps": -6.4, "forwardEps": -3.1989, "enterpriseToRevenue": 436.602, "enterpriseToEbitda": -8.708, "52WeekChange": 0.7219626, "SandP52WeekChange": 0.17318606, "quoteType": "EQUITY", "currentPrice": 29.48, "targetHighPrice": 75.0, "targetLowPrice": 35.0, "targetMeanPrice": 47.57143, "targetMedianPrice": 43.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 372427008, "totalCashPerShare": 6.892, "ebitda": -140332000, "totalDebt": 1419000, "quickRatio": 31.469, "currentRatio": 32.669, "totalRevenue": 2799000, "debtToEquity": 0.375, "revenuePerShare": 0.054, "returnOnAssets": -0.28152, "returnOnEquity": -0.408, "grossProfits": 2799000, "freeCashflow": -87004000, "operatingCashflow": -122256000, "revenueGrowth": 0.125, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -55.39385, "financialCurrency": "USD", "symbol": "UPB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "messageBoardId": "finmb_1773603947", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyTwoWeekLowChange": 24.34, "fiftyTwoWeekLowChangePercent": 4.735409, "fiftyTwoWeekRange": "5.14 - 33.0", "fiftyTwoWeekHighChange": -3.5200005, "fiftyTwoWeekHighChangePercent": -0.106666684, "fiftyTwoWeekChangePercent": 72.19626, "earningsTimestamp": 1762349400, "earningsTimestampStart": 1762349400, "earningsTimestampEnd": 1762349400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -6.4, "epsForward": -3.1989, "epsCurrentYear": -2.57588, "priceEpsCurrentYear": -11.444633, "fiftyDayAverageChange": 3.5555, "fiftyDayAverageChangePercent": 0.13714826, "twoHundredDayAverageChange": 13.577475, "twoHundredDayAverageChangePercent": 0.8537936, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -2.60985, "regularMarketPrice": 29.48, "marketState": "CLOSED", "longName": "Upstream Bio, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1728653400000, "postMarketChangePercent": -1.628221, "postMarketPrice": 29.0, "postMarketChange": -0.47999954, "regularMarketChange": -0.790001, "regularMarketDayRange": "29.1 - 30.11", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 460890, "exchange": "NMS", "shortName": "Upstream Bio, Inc.", "corporateActions": [], "postMarketTime": 1766793822, "regularMarketTime": 1766782800, "displayName": "Upstream Bio", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]